ALLERGEN | VANCOUVER, % (N = 821) | OTTAWA,* % (N = 100) | NACDG 2015-2016, % (N = 5597) |
---|---|---|---|
Bacitracin | 4.0 | 44 | 6.9 |
Neomycin | 3.2 | 29 | 7.0 |
Lidocaine | 2.3 | 12 | 0.8 |
Propylene glycol | 1.8 | Not analyzed | 2.8 |
Tixocortol-21-pivalate | 1.5 | 19 | 2.1 |
NACDG—North American Contact Dermatitis Group.
↵*The Ottawa cohort included only patients with positive reactions to ≥ 1 topical medicament ingredients.